“a nonsignificant trend”

Individuals in cluster G ( SMARCA4 -mutant tumors) had a nonsignificant trend towards a younger age at diagnosis ( P = 0.32).

The FLT‐binding ratio of SVZ showed significant positive correlation with the infarct volume ( r = 0.84, p < 0.001), and a nonsignificant trend toward negative correlation with age ( r = −0.30, p = 0.323) (Fig.

There was a nonsignificant trend for a higher tadpole number decline rate in tree‐fall gaps than in the closed forest (effect = −0.022 ± 0.021, t = −1.044 P = 0.327; Fig. 6 ).

There was a nonsignificant trend for better performance with direct-audio input, t (19) = 0.97, p = .345.

Losartan treatment significantly increased plasma concentrations of ANG II in NI and 5 days I3C-induced rats, with a nonsignificant trend toward an increase in 13 days I3C-induced rats ( p = 0.3473). 5 days I3C-induction led to about 4-fold higher kidney ANG II levels in comparison to NI rats, which were significantly reduced after 13 days I3C-induction, but to levels statistically higher than NI rats (164.6 ± 12.6 vs. 216.1 ± 9.6 vs. 57.2 ± 4.2 fmol/g).

Following denervation, a nonsignificant trend towards blood pressure reduction was found (SBP −7.1 ± 6.9 mmHg, p = 0.35; DBP −0.6 ± 4.0 mmHg, p = 0.88) at 6 months, with no hypotensive events noted.

Caffeine consumption was associated with a nonsignificant trend toward higher recurrence (OR 1.67; 95% CI: 0.56–4.96; p = 0.35).

48.6%, p < 0.001), with a nonsignificant trend toward fewer G3 tumours compared with ER-high (21.5% vs. 27.0%, p = 0.350).

There was a nonsignificant trend towards lower EC50: (0.27 ± 0.3 vs 0.36 ± 0.6 U/l; P = 0.36) ( Figure 5 ) for aggregation induced by thrombin in platelets from MetS pigs compared with lean controls.

In addition, ppargc1al (zebrafish homologue of human PPARGC1A , also called PGC-1α ), a gene involved in fatty acid oxidation, showed a nonsignificant trend towards ( P = 0.36) increased expression with eriocitrin feeding ( Table 2 ).

2.7 months [ n = 75]; HR 0.34 [IC95%: 0.20–0.56]; p < 0.001), and a nonsignificant trend was observed for CRT (8.1 months [ n = 13] vs. 3.3 months [ n = 86]; p = 0.36).

A nonsignificant trend towards longer survival was observed in those with low UBC9 levels ( P= 0.36), those with low BRCA1 levels ( P= 0.36) and those with low MDC1 levels ( P= 0.67).

As shown in Figure 1 , the simple slope analyses indicated that state narcissism predicted more donations in the public situation, B = 2.42, SE = 0.42, 95%CI = [1.59, 3.25], t (196) = 5.76, p < 0.001, but there was a nonsignificant trend in the anonymous situation, B = 0.38, SE = 0.42, 95%CI = [−0.45, 1.21], t (196) = 0.91, p = 0.36.

There appeared to be a nonsignificant trend toward ESA leading to a further decrease in A1C following the initial fall due to iron (mean A1C 7.3–6.9%, P = 0.36 following iron and 6.9–6.7%, P = 0.13 following ESA).

There was a nonsignificant trend for the RV during the steady state (V ss ) to be on average 58% higher in the patients compared with the control limbs ( P = .364) ( Fig 8 ).

4k , P = 0.054), while the frequency of expanded pr T H 1 CTL-like cells within the pr T H 1 CTL cluster or among pr T eff memory cells showed a nonsignificant trend toward higher values in SU compared to DS participants at week 117 (Fig. 4j , P = 0.37; Fig. 4k , P = 0.17).

When controlling for IDH1 and TERT promoter status, B7-H4 expression, and new or recurrent disease, the experimental arm had more significantly prolonged OS (HR 2.5, P=0.02) and a nonsignificant trend toward improved PFS (HR 1.37, P=0.37).

There was a nonsignificant trend toward more liver abscesses in the patients with XL inheritance (31%) than those with AR inheritance (14%, P = 0.37; 6 of our 7 patients with liver abscesses had XL inheritance).

High expression of Thy-1 is associated with a nonsignificant trend toward shorter progression-free survival in women with Stage I/II endometrioid ovarian cancer (A, P = 0.37, n = 28), but is associated with significantly shorter progression-free survival in women with Stage III/IV endometrioid ovarian cancer (B, P = 0.001, n = 21).

In contrast, while DOAC use was associated with a reduced risk of other critical‐site bleeding (sHR, 0.17; 95% CI, 0.05–0.58; p < 0.01), it was linked to an increased risk of gastrointestinal bleeding (sHR, 3.00; 95% CI, 1.94–4.64; p < 0.01), alongside a nonsignificant trend toward lower intracranial hemorrhage risk (sHR, 0.79; 95% CI, 0.47–1.33; p = 0.37) compared with LMWH use. 3.4 Subgroup Analyses Focusing on Recurrent VTE and Bleeding As illustrated in Figure 3A , our subgroup analysis of recurrent VTE associated with GI cancer highlights that patients under 65 years of age demonstrated a reduced risk of VTE when treated with DOACs.

To further assess whether estrobolome-associated pathways might be affected with age, we examined changes in β-glucuronidase activity in female mice predicted using PICRUSt2, which revealed a nonsignificant trend of decreased β-glucuronidase activity with age ( P value ~ 0.3759; Fig. 1i ).

There was a nonsignificant trend toward reduction of the primary outcome of composite CVD and renal disease with the intensive treatment strategy (10.6 versus 12.0 per 1000 patient‐y; P =0.38) at 3 years of follow‐up.

A nonsignificant trend towards increased mammary tumour incidence was found for parous MMTV-c- myc transgenic/ bax -hemizygous mice (44.4 vs 20 and 20%; P =0.39 by Wilcoxon) as compared to parous c- myc transgenic mice in which bax was intact or completely eliminated ( Figure 1B ).

3 , 9 Outpatient surgery demonstrated a nonsignificant trend toward reduced readmission rates compared to inpatient surgery (OR 0.496, 95% CI 0.08-2.69, P = .39), with high heterogeneity (I 2 = 67.93%).

At the time of cystectomy, those 18 patients were compared to 12 who had undergone immediate cystectomy and found to have a nonsignificant trend towards improved survival in the immediate cystectomy group (5-yr CSS60% v. 72%, p = 0.39).